The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction - Top-Institutions - MDSpire

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction

  • By

  • Sergio González-Serrano

  • Alina-Iuliana Onoiu

  • Andrea Jiménez-Franco

  • Vicente Cambra-Cortés

  • Jordi Camps

  • Jorge Joven

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Immunology
    • Metabolic Diseases

  • #2

    University of California, San Diego (UCSD) - Division of Gastroenterology and Hepatology
    University of California, San Diego (UCSD) - Division of Gastroenterology and Hepatology

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Immunometabolism
    • Translational Medicine

  • #3

    Mount Sinai Health System - Icahn School of Medicine at Mount Sinai
    Mount Sinai Health System - Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Hepatology
    • Immunology
    • Metabolic Research

  • #4

    University of California, San Francisco (UCSF) - Liver Center
    University of California, San Francisco (UCSF) - Liver Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Immunometabolism
    • Clinical Research

  • #5

    Cleveland Clinic - Digestive Disease & Surgery Institute
    Cleveland Clinic - Digestive Disease & Surgery Institute

    Cleveland, OH

    Key Differentiators

    • Hepatology
    • Immunology
    • Metabolic Disorders

Original Source(s)

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction

  • by Sergio González-Serrano, Alina-Iuliana Onoiu, Andrea Jiménez-Franco, Vicente Cambra-Cortés, Jordi Camps, Jorge Joven

  • April 30, 2026

Related Content

A Mindfulness-Based Intervention for Binge Eating, Self-Compassion, and Mindfulness in Brazilian Women With Weight Regain After Metabolic and Bariatric Surgery: a Pilot Feasibility Study

Transforming obesity medicine with artificial intelligence: personalization, precision and the path ahead

TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study